SELLAS Life Sciences Group, Inc.SLSNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
10.45%
↑ 109% above average
Average (39q)
-122.15%
Historical baseline
Range
High:132.20%
Low:-1575.98%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 10.45% |
| Q2 2025 | -1.21% |
| Q1 2025 | -501.82% |
| Q4 2024 | 89.00% |
| Q3 2024 | 23.08% |
| Q2 2024 | 38.10% |
| Q1 2024 | 16.00% |
| Q4 2023 | -588.71% |
| Q3 2023 | -4.91% |
| Q2 2023 | 32.82% |
| Q1 2023 | -13.19% |
| Q4 2022 | -23.98% |
| Q3 2022 | 91.05% |
| Q2 2022 | -241.67% |
| Q1 2022 | -159.74% |
| Q4 2021 | 89.73% |
| Q3 2021 | -50.00% |
| Q2 2021 | -1575.98% |
| Q1 2021 | 63.47% |
| Q4 2020 | 90.75% |
| Q3 2020 | 19.70% |
| Q2 2020 | 0.00% |
| Q1 2020 | -407.69% |
| Q4 2019 | 95.15% |
| Q3 2019 | 57.66% |
| Q2 2019 | 43.08% |
| Q1 2019 | -230.95% |
| Q4 2018 | 87.44% |
| Q3 2018 | 57.54% |
| Q2 2018 | 24.55% |
| Q1 2018 | -1222.31% |
| Q4 2017 | 128.84% |
| Q3 2017 | 88.53% |
| Q2 2017 | -23.97% |
| Q1 2017 | -122.67% |
| Q4 2016 | 91.77% |
| Q3 2016 | -1103.15% |
| Q2 2016 | 132.20% |
| Q1 2016 | 24.36% |
| Q4 2015 | -9.14% |